MedPath

Incidence Rate of Heart Failure After Acute Myocardial Infarction With Optimal Treatment

Completed
Conditions
Acute Myocardial Infarction
Heart Failure
Registration Number
NCT03297164
Lead Sponsor
Harbin Medical University
Brief Summary

The main purpose of this study is to build a multi-center, prospective and regionally representative acute myocardial infarction(AMI) cohort,and build a study platform for heart failure caused by AMI; To explore the 1 year incidence rate of heart failure after AMI given the optimized treatment and the treatment model affecting the incidence rate of heart failure, and finally to reduce the incidence rate of heart failure by 5%.

Detailed Description

the study aim to enroll 12000 acute myocardial infartion (AMI) patients, including ST-segment elevation myocardial infarction (STEMI) and non ST-segment elevation myocardial infarction (NSETMI), Patients were divided into two groups(optimized group and un-optimized group) according to treatment models they accepted in 20 reginally representative hosptials of China. whether optimizaed or not is judged by 4 four aspects,including emergency treatment procedure, pre-infusion medication, reperfusion strategy selection, and early rehabilitation after reperfusion.Patients were followed at 1 month, 6 months and 12 months. The physical condition and clinical events(heart failure, death, re-infarction, revascularization, apoplexy, malignant arrhythmias, bleeding events, other adverse events)were collected at follow up.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12043
Inclusion Criteria
  • age≥18 years
  • diagnosed acute myocardial infarction
  • signed the informed consent form
Exclusion Criteria
  • AMI is caused by surgery, trauma, gastrointestinal bleeding or complications of PCI;
  • AMI occurred in patients who have been hospitalized for other reasons;
  • patients with previous history of chronic heart failure;
  • researchers judging that patient's compliance was poor and could not complete the study according to the requirements.
  • life expectancy is less than 12 months;
  • heart transplant patients;
  • patients with tumors;

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
incidence rate of heart failure12th month after diacharge

incidence rate of heart failure of acute myocardial infarction at 12th month

Secondary Outcome Measures
NameTimeMethod
MACCE rate12th month after diacharge

the major adverse cardiac celebral events including death,reinfarction,

bleeding rate12th month after diacharge

the incidence rate of bleeding

severe adverse drug reactions12th month after diacharge

severe adverse drug reactions at 12th month

Trial Locations

Locations (19)

Guangdong general hospital

🇨🇳

Guangzhou, Guangdong, China

Zhongda Hospital Southeast University

🇨🇳

Nanjing, Jiangsu, China

Daqing Oilfield General Hospital

🇨🇳

Daqing, Heilongjiang, China

The first affiliated hospital of Guangxi medical university

🇨🇳

Nanning, Guangxi, China

Second hospital of hebei medical university

🇨🇳

Shijiazhuang, Hebei, China

Beijing An Zhen Hospital, Capital Medical University

🇨🇳

Beijing, Beijing, China

The first affiliated hospital of Zhengzhou medical university

🇨🇳

Zhengzhou, Henan, China

The Second Affiliated Hospital of Nanchang University

🇨🇳

Nanchang, Jiangxi, China

the second affiliated hospital of Dalian medical university

🇨🇳

Dalian, Liaoning, China

Shenyang military district general hospital of the people's liberation army

🇨🇳

Shenyang, Liaoning, China

The first affiliated hospital of military medical university

🇨🇳

Xi'an, Shanxi, China

Third Military Medical University

🇨🇳

Chongqing, Sichuan, China

Tianjin Chest Hospital

🇨🇳

Tianjing, Tianjin, China

The General Hospital of Tianjin Medical University

🇨🇳

Tianjin, Tianjin, China

Peking Univerisity People'Hospital

🇨🇳

Beijing, Beijing, China

Beijing Chao-Yang Hospital, Capital Medical University

🇨🇳

Beijing, Beijing, China

The Second Hospital of Jilin University

🇨🇳

Changchun, Jilin, China

The First Affiliated Hospital of Xinjiang Medical University

🇨🇳

Urumqi, Xinjiang, China

Peking University First Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath